Related references
Note: Only part of the references are listed.A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity!
Ashley Patton et al.
GENES CHROMOSOMES & CANCER (2022)
The TAZ-CAMTA1 Fusion Protein Promotes Tumorigenesis via Connective Tissue Growth Factor and Ras-MAPK Signaling in Epithelioid Hemangioendothelioma
Shuang Ma et al.
CLINICAL CANCER RESEARCH (2022)
Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex
Kepeng Che et al.
PLOS ONE (2022)
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
Shenghong Ma et al.
NATURE COMMUNICATIONS (2022)
Letter by Seavey and Rubin Regarding Article, Sustained Activation of Endothelial YAP1 Causes Epithelioid Hemangioendothelioma
Caleb N. Seavey et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
CAMTA1, a novel antitumor gene, regulates proliferation and the cell cycle in glioma by inhibiting AKT phosphorylation
Zongze He et al.
CELLULAR SIGNALLING (2021)
Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung
Abbas Agaimy et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
WWTR1(TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis
Caleb N. Seavey et al.
GENES & DEVELOPMENT (2021)
WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma
Jordan H. Driskill et al.
GENES & DEVELOPMENT (2021)
TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
Nicole Merritt et al.
ELIFE (2021)
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity
Joel D. Pearson et al.
CANCER CELL (2021)
YAP1-TFE3 gene fusion variant in clear cell stromal tumour of lung: report of two cases in support of a distinct entity
Josephine K. Dermawan et al.
HISTOPATHOLOGY (2021)
YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases
Josephine K. Dermawan et al.
MODERN PATHOLOGY (2021)
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian rare cancer network
Silvia Stacchiotti et al.
CANCER (2021)
Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets
Evan Rosenbaum et al.
MODERN PATHOLOGY (2020)
Variant WWTR1 gene fusions in epithelioid hemangioendothelioma-A genetic subset associated with cardiac involvement
Albert J. H. Suurmeijer et al.
GENES CHROMOSOMES & CANCER (2020)
Modulation of YAP/ TAZ by statins to improve survival in epithelioid hemangioendothelioma (EHE).
Aparna Subramaniam et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis
Frank Szulzewsky et al.
GENES & DEVELOPMENT (2020)
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Ajaybabu Pobbati et al.
THERANOSTICS (2020)
TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC
Stacy Grieve et al.
BLOOD ADVANCES (2019)
Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma
Nathan D. Seligson et al.
JAMA NETWORK OPEN (2019)
CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties
Taku Wakabayashi et al.
CELL STEM CELL (2018)
PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways
Yulei Zhao et al.
MOLECULAR CANCER RESEARCH (2018)
YAP/TAZ upstream signals and downstream responses
Antonio Totaro et al.
NATURE CELL BIOLOGY (2018)
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
T. Azad et al.
NATURE COMMUNICATIONS (2018)
Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma
John M. Lamar et al.
CANCERS (2018)
Activation mechanisms of the Hippo kinase signaling cascade
Sung Jun Bae et al.
BIOSCIENCE REPORTS (2018)
Hippo signaling dysfunction induces cancer cell addiction to YAP
Han Han et al.
ONCOGENE (2018)
1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin
Hiba Sabra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Andreas Hochhaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
Wenyi Mi et al.
NATURE COMMUNICATIONS (2017)
The Epithelial Circumferential Actin Belt Regulates YAP/TAZ through Nucleocytoplasmic Shuttling of Merlin
Kana T. Furukawa et al.
CELL REPORTS (2017)
Multiparametric Analysis of Cell Shape Demonstrates that β-PIX Directly Couples YAP Activation to Extracellular Matrix Adhesion
Julia E. Sero et al.
CELL SYSTEMS (2017)
Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein
M. R. Tanas et al.
ONCOGENE (2016)
Identification of blood vascular endothelial stem cells by the expression of protein C receptor
Qing Cissy Yu et al.
CELL RESEARCH (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Control of YAP/TAZ Activity Metabolic anc Nutrient-Sensing Pathways
Giulia Santinon et al.
TRENDS IN CELL BIOLOGY (2016)
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis
Katherine Martin et al.
NATURE COMMUNICATIONS (2016)
Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1
Li-Juan Ding et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The calmodulin-binding transcription activator CAMTA1 is required for long-term memory formation in mice
Carlos Bas-Orth et al.
LEARNING & MEMORY (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma
Ryo Shibuya et al.
HISTOPATHOLOGY (2015)
YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant
Florian Puls et al.
VIRCHOWS ARCHIV (2015)
Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
Xiaodong Feng et al.
CANCER CELL (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas†
M. Agulnik et al.
ANNALS OF ONCOLOGY (2013)
Sorafenib in patients with progressive epithelioid hemangioendothelioma
Christine Chevreau et al.
CANCER (2013)
Emerging roles of TEAD transcription factors and its coactivators in cancers
Ajaybabu V. Pobbati et al.
CANCER BIOLOGY & THERAPY (2013)
Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2
Feng Yin et al.
CELL (2013)
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
Mariaceleste Aragona et al.
CELL (2013)
Regulation of Hippo Signaling by EGFR-MAPK Signaling through Ajuba Family Proteins
B. V. V. G. Reddy et al.
DEVELOPMENTAL CELL (2013)
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma
Cristina R. Antonescu et al.
GENES CHROMOSOMES & CANCER (2013)
Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1
Run Fan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells
Krishanpal Karmodiya et al.
BMC GENOMICS (2012)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes
Ajaybabu V. Pobbati et al.
STRUCTURE (2012)
CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells
Kai-Oliver Henrich et al.
CANCER RESEARCH (2011)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Clinical Patterns and Outcome in Epithelioid Hemangioendothelioma With or Without Pulmonary Involvement Insights From an Internet Registry in the Study of a Rare Cancer
Kenneth Lau et al.
CHEST (2011)
Tao-1 Phosphorylates Hippo/MST Kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor Pathway
Julian C. Boggiano et al.
DEVELOPMENTAL CELL (2011)
CAMTA1 is a novel tumour suppressor regulated by miR-9/9*in glioblastoma stem cells
Daniel Schraivogel et al.
EMBO JOURNAL (2011)
A Novel WWTR1-CAMTA1 Gene Fusion Is a Consistent Abnormality in Epithelioid Hemangioendothelioma of Different Anatomic Sites
Costantino Errani et al.
GENES CHROMOSOMES & CANCER (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Munir R. Tanas et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor
Min S. Park et al.
CURRENT OPINION IN ONCOLOGY (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase
Chen-Ying Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Double-Histone-Acetyltransferase Complex ATAC Is Essential for Mammalian Development
Sebastian Guelman et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
Jianmin Zhang et al.
NATURE CELL BIOLOGY (2009)
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells
Siew Wee Chan et al.
CANCER RESEARCH (2008)
MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation
Maria Praskova et al.
CURRENT BIOLOGY (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway
Qun-Ying Lei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
ATAC is a double histone acetyltransferase complex that stimulates nucleosome sliding
Tamaki Suganuma et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance
Matthew J. Huentelman et al.
HUMAN MOLECULAR GENETICS (2007)
Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: A review of the literature
Patrick Bagan et al.
ANNALS OF THORACIC SURGERY (2006)
The Drosophila histone acetyltransferase Gcn5 and transcriptional adaptor Ada2a are involved in nucleosomal histone H4 acetylation
Anita Ciurciu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report
Randa M. S. Amin et al.
RESPIROLOGY (2006)
Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation
Bernard A. Callus et al.
FEBS JOURNAL (2006)
The human tumour suppressor LATS1 is activated by human MOB1 at the membrane
Alexander Hergovich et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Histone H4-K16 acetylation controls chromatin structure and protein interactions
M Shogren-Knaak et al.
SCIENCE (2006)
Host cell factor and an uncharacterized SANT domain protein are stable components of ATAC, a novel dAda2A/dGcn5-containing histone acetyltransferase complex in Drosophila
S Guelman et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
M Deininger et al.
BLOOD (2005)
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
EH Chan et al.
ONCOGENE (2005)
Mesenchymal stem cells can be differentiated into endothelial cells in vitro
J Oswald et al.
STEM CELLS (2004)
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
MC Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis
KF Harvey et al.
CELL (2003)
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts
S Wu et al.
CELL (2003)
salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines
N Tapon et al.
CELL (2002)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development
E Steingrimsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma
MR Mendlick et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Share Paper
